Merck Healthcare

Merck Healthcare. It is one of the three core business sectors of the global science and technology company Merck Group, a German multinational with a history dating back to 1668. The division focuses on developing and commercializing innovative prescription medicines, biologic therapies, and established Over-the-counter drug products across key therapeutic areas. With a significant global footprint, it operates in highly competitive markets, investing heavily in Research and development to address unmet medical needs in Oncology, Cardiology, Fertility, and Endocrinology.

History

The healthcare business originates from the Apothecary founded by Friedrich Jacob Merck in Darmstadt, which evolved into the modern Merck Group. A pivotal moment occurred in 2007 when the company acquired the Swiss biotech firm Serono, significantly expanding its presence in Biopharmaceuticals and establishing a major research hub in Boston. This was followed by the acquisition of Sigma-Aldrich in 2015, bolstering its life science tools division, though the healthcare sector remained distinct. Throughout the 20th century, the division developed key products like Concor and later expanded its portfolio through strategic partnerships with organizations like the Bill & Melinda Gates Foundation for global health initiatives.

Business segments

The division's operations are structured into two primary business lines: Prescription Medicines and Consumer Health. The Prescription Medicines unit is the core growth driver, focusing on innovative therapies in areas such as Oncology, Cardiology, and Fertility. The Consumer Health segment markets well-known Over-the-counter drug brands and self-care products, including Neurobion and Femibion, primarily in Europe and Latin America. This dual structure allows the division to balance high-growth, research-intensive activities with stable, cash-generating consumer brands, operating under the global regulatory frameworks of agencies like the Food and Drug Administration and the European Medicines Agency.

Key products and therapies

Its portfolio includes several blockbuster and established medicines. In Oncology, Bavencio (avelumab), developed in partnership with Pfizer, is a key Immunotherapy for treating Merkel cell carcinoma and Urothelial carcinoma. The cardiology franchise is anchored by Concor (bisoprolol), a widely used Beta blocker. In Fertility, the division is a global leader with products like Gonal-f (follitropin alfa), a Recombinant DNA hormone. The Endocrinology portfolio includes Euthyrox for Thyroid disorders. The Consumer Health unit offers brands such as Neurobion for B-vitamin deficiencies and Femibion for pregnancy nutrition, sold in markets including Germany and Brazil.

Research and development

Research and development is centered on discovering novel treatments in Oncology, Immunology, and Neurology. Major R&D hubs are located in Boston, Darmstadt, and Lausanne, leveraging collaborations with academic institutions like Harvard University and biotech companies. A core strategic focus is on Immuno-oncology, with significant investments in next-generation immunotherapies and Biomarker discovery. The division also pursues Drug discovery in areas like Multiple sclerosis and Alzheimer's disease, often through alliances with firms such as Teva Pharmaceutical Industries and research consortia like the Innovative Medicines Initiative.

Corporate affairs and operations

The division operates as an integral part of the Merck Group, which is headquartered in Darmstadt and led by Chair and CEO Belén Garijo. It maintains a global commercial presence, with key operational sites in Switzerland, the United States, and Asia. The division actively engages in Corporate social responsibility programs, focusing on improving healthcare access in developing countries through partnerships with UNICEF and the World Health Organization. It adheres to strict Good manufacturing practice standards across its manufacturing network and navigates complex Intellectual property landscapes and pricing pressures from systems like the National Health Service in the United Kingdom.